Alector Inc

CEO Arnon’s 116k‑share RSU purchase signals long‑term confidence in Alector’s neuro‑therapeutic pipeline, offering investors insight into insider sentiment and future capital flow.

Grace Wong‑Sarad’s 1,000‑share sale at $2.65 shows routine Alector insider trading; investors can gauge impact on shares amid steady pipeline growth.

Insider selling at Alector Inc. shows a planned 10b5‑1 strategy—executive sales amid a 29% price surge—highlighting potential liquidity moves and future funding signals.